Page last updated: 2024-12-09

2-mercaptobenzimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-mercaptobenzimidazole: purine synthesis antimetabolite; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID707035
CHEMBL ID70141
SCHEMBL ID1872555
SCHEMBL ID36857
SCHEMBL ID1236095
MeSH IDM0096909

Synonyms (130)

Synonym
BIDD:GT0154
2-merkaptobenzimidazol
619cvm6hok ,
benzimidazoline-2-thione
unii-619cvm6hok
2-benzimidazolinthion
ec 209-502-6
BB 0242024
STL294808
wln: t56 bmymj cus
2-thiol benzimidazole
aomb
1h-benzimidazole-2-thiol
mercaptobenzimidazole
583-39-1
2-mercaptobenzimidazole
mercaptobenzoimidazole
anitiegene mb
2-thiobenzimidazole
usaf xf-21
nsc186246
2-mercaptobenzoimidazole
antiegene mb
permanax 21
usaf ek-6540
nci-c56268
wln: t56 bm dnj csh
antigen mb
o-phenylenethiourea
asm mb
antioxidant mb
antigene mb
merkaptobenzimidazol
2-benzimidazolinethione
nsc-186246
2-benzimidazolethiol
nsc-21414
nsc21414
5468-83-7
MLS000420224
smr000322777
AH-034/32845023
1,3-dihydrobenzimidazole-2-thione
2(3h)-benzimidazolethione
NCGC00091164-01
nsc 21414
2-benzimidazolinthion [czech]
merkaptobenzimidazol [czech]
antioxidant mb [czech]
2-merkaptobenzimidazol [czech]
nci-c60980
benzimidazolethiol
ccris 4837
benzimidazole-2-thiol
ai3-18633
nsc 186246
einecs 209-502-6
2h-benzimidazole-2-thione, 1,3-dihydro-
2-mercaptobenzimidazole, 98%
SR-01000637371-1
MAYBRIDGE1_006897
1,3-dihydro-2h-benzimidazole-2-thione
STK394298
AC-6272
B0055
CHEMBL70141
HMS561B11
AKOS000119126
NCGC00091164-02
HMS2671C17
2-benzimidazole thiol
cas-583-39-1
dtxcid805536
NCGC00257094-01
dtxsid9025536 ,
tox21_303274
NCGC00259377-01
tox21_201828
SCHEMBL1872555
BBL011714
134469-07-1
1h-benzoimidazole-2-thiol
CCG-47778
2-mercapto-1h-benzimidazole
FT-0671082
FT-0643221
2-mercapto benzimidazole
FT-0612739
1h-1,3-benzodiazole-2-thiol
FS-2658
AM90365
mercaptobenzimidazole, 2-
lansoprazole impurity e [ep impurity]
2-benzimidazolethiol [mi]
mercaptobenzimidazole [usp impurity]
rabeprazole sodium impurity f [ep impurity]
BBL023512
1h-benzo[d]imidazole-2-thiol
AKOS016371491
SCHEMBL36857
J-504656
SCHEMBL1236095
1h-benzoimidazol-2-thiol
2-mercaptobenzimidazol
1,3-dihydro-benzimidazole-2-thione
2-mercapto-1 h-benzimidazole
2-mercapto-benzimidazole
2mercaptobenzimidazole
1h-benzo[d]imidazole-2(3h)-thione
2-sulfanylbenzimidazole
2-mercapto-1h-benzimidazol
S 00965
Q-101102
F0074-0053
mfcd00005593
2-mercaptobenzimidazole, analytical standard
1,3-dihydro-2h-benzo[d]imidazole-2-thione
lansoprazole ep impurity e
CS-W023180
1h-benzimidazole-2(3h)-thione
BCP21899
Q16004147
W11093
2-benzimidazolethiol; benzimidazole-2-thiol
A930054
STARBLD0019593
PD148021
bdbm50570899
EN300-21475
Z203045044

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" No adverse effects on fetuses were found at doses < or = 40 mg/kg."( The adverse effects of oral 2-mercaptobenzimidazole on pregnant rats and their fetuses.
Morita, S; Noda, T; Shimizu, M; Yamano, T, 1995
)
0.59
" No toxic deaths occurred due to 2-MBI treatment."( Toxicity study of a rubber antioxidant, 2-mercaptobenzimidazole, by repeated oral administration to rats.
Inoue, T; Isama, K; Kawasaki, Y; Kurokawa, Y; Matsumoto, M; Matsushima, Y; Momma, J; Saito, M; Sakemi, K; Sekiguchi, H; Tsuda, M; Umemura, T, 1998
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (49)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.35480.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency28.18380.004023.8416100.0000AID485290
Chain A, Beta-lactamaseEscherichia coli K-12Potency12.58930.044717.8581100.0000AID485294
Chain A, HADH2 proteinHomo sapiens (human)Potency39.81070.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency39.81070.025120.237639.8107AID886
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency28.18380.631035.7641100.0000AID504339
LuciferasePhotinus pyralis (common eastern firefly)Potency79.64070.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency45.09640.002541.796015,848.9004AID1347397; AID1347398; AID1347399
GLI family zinc finger 3Homo sapiens (human)Potency30.70020.000714.592883.7951AID1259369
Microtubule-associated protein tauHomo sapiens (human)Potency8.91250.180013.557439.8107AID1468
AR proteinHomo sapiens (human)Potency4.17930.000221.22318,912.5098AID743040; AID743042; AID743054
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency21.48650.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency54.59350.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency36.98860.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.96720.000214.376460.0339AID720691; AID720692; AID720719
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency30.67780.001530.607315,848.9004AID1224841
farnesoid X nuclear receptorHomo sapiens (human)Potency37.45050.375827.485161.6524AID743217; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency64.92990.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency33.20840.000229.305416,493.5996AID743075; AID743079; AID743080
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency37.05150.001024.504861.6448AID743212; AID743215
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency12.58930.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency49.69690.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency17.73280.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency68.72910.001628.015177.1139AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency17.373919.739145.978464.9432AID1159509
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency74.97800.000627.21521,122.0200AID651741
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency10.00000.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Glycoprotein hormones alpha chainHomo sapiens (human)Potency11.22024.46688.344810.0000AID624291
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Nuclear receptor ROR-gammaHomo sapiens (human)Potency33.49150.026622.448266.8242AID651802
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency10.00001.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Proteasome subunit beta type-8Homo sapiens (human)IC50 (µMol)114.00000.00130.36985.0000AID1763210
Glutaminyl-peptide cyclotransferaseHomo sapiens (human)IC50 (µMol)551.00005.00005.00005.0000AID1893771
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (33)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell population proliferationGlycoprotein hormones alpha chainHomo sapiens (human)
hormone-mediated signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
regulation of signaling receptor activityGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of steroid biosynthetic processGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of cell migrationGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid gland developmentGlycoprotein hormones alpha chainHomo sapiens (human)
luteinizing hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone signaling pathwayGlycoprotein hormones alpha chainHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlycoprotein hormones alpha chainHomo sapiens (human)
negative regulation of organ growthGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone secretionGlycoprotein hormones alpha chainHomo sapiens (human)
thyroid hormone generationGlycoprotein hormones alpha chainHomo sapiens (human)
antigen processing and presentationProteasome subunit beta type-8Homo sapiens (human)
fat cell differentiationProteasome subunit beta type-8Homo sapiens (human)
regulation of endopeptidase activityProteasome subunit beta type-8Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProteasome subunit beta type-8Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferaseGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
protein modification processGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
protein bindingGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone activityGlycoprotein hormones alpha chainHomo sapiens (human)
threonine-type endopeptidase activityProteasome subunit beta type-8Homo sapiens (human)
protein bindingProteasome subunit beta type-8Homo sapiens (human)
endopeptidase activityProteasome subunit beta type-8Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
zinc ion bindingGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
glutaminyl-peptide cyclotransferase activityGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
extracellular regionGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
Golgi lumenGlycoprotein hormones alpha chainHomo sapiens (human)
follicle-stimulating hormone complexGlycoprotein hormones alpha chainHomo sapiens (human)
pituitary gonadotropin complexGlycoprotein hormones alpha chainHomo sapiens (human)
extracellular spaceGlycoprotein hormones alpha chainHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
nucleoplasmProteasome subunit beta type-8Homo sapiens (human)
cytosolProteasome subunit beta type-8Homo sapiens (human)
extracellular exosomeProteasome subunit beta type-8Homo sapiens (human)
proteasome complexProteasome subunit beta type-8Homo sapiens (human)
proteasome core complexProteasome subunit beta type-8Homo sapiens (human)
proteasome core complex, beta-subunit complexProteasome subunit beta type-8Homo sapiens (human)
spermatoproteasome complexProteasome subunit beta type-8Homo sapiens (human)
nucleusProteasome subunit beta type-8Homo sapiens (human)
cytosolProteasome subunit beta type-8Homo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
extracellular regionGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
specific granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
extracellular exosomeGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
tertiary granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
ficolin-1-rich granule lumenGlutaminyl-peptide cyclotransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID614063Inhibition of bovine testes hyaluronidase at 80 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID284279Antiamnesic activity against Entamoeba histolytica2007Bioorganic & medicinal chemistry, Jan-15, Volume: 15, Issue:2
Molecular modeling of some 1H-benzimidazole derivatives with biological activity against Entamoeba histolytica: a comparative molecular field analysis study.
AID1763210Inhibition of human chymotrypsin-like beta 5i subunit of iCP using suc-LLVY-AMC as flurogenic substrate for 90 mins by fluorescence-based assay2021European journal of medicinal chemistry, Jul-05, Volume: 219Discovery of selective fragment-sized immunoproteasome inhibitors.
AID614062Inhibition of bovine testes hyaluronidase at 63 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID584546Inhibition of inosine/L-alanine-induced Bacillus anthracis Sterne 34F2 spore germination pretreated for 15 mins before inosine/L-alanine challenge2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID614053Inhibition of bovine testes hyaluronidase at 4200 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1389532Inhibition of DAAO (unknown origin) at 20 uM2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
AID614055Inhibition of bovine testes hyaluronidase at 180 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614056Inhibition of bovine testes hyaluronidase at 190 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614061Inhibition of bovine testes hyaluronidase at 130 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID67529The compound was tested in vitro against the protozoa Entamoeba histolytica, for the inhibition of tubulin polymerization in rat brain2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.
AID614051Inhibition of bovine testes hyaluronidase at 380 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614057Inhibition of bovine testes hyaluronidase at 170 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1763219Inhibition of beta 5 chymotrypsin-like activity (unknown origin) at 100 uM using Suc-LLVY-AMC as substrate for 90 mins by fluorescence based assay2021European journal of medicinal chemistry, Jul-05, Volume: 219Discovery of selective fragment-sized immunoproteasome inhibitors.
AID614060Inhibition of bovine testes hyaluronidase at 3800 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614044Inhibition of Streptococcus agalactiae 4755 hyaluronidase at pH 7.4 after 3 hrs by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614065Inhibition of bovine testes hyaluronidase at 150 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID75268The compound was tested in vitro against the protozoa Giardia lamblia, for the inhibition of tubulin polymerization in rat brain2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.
AID614054Inhibition of bovine testes hyaluronidase at 460 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614050Inhibition of bovine testes hyaluronidase at 200 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID210973Percentage viability reduction of Trichinella spiralis muscle larvae after 3 days of incubation2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.
AID584547Antibacterial activity against Bacillus anthracis Sterne 34F2 infected in mouse J774A.1 cells assessed as protection against bacteria-induced cytotoxicity using propidium iodide staining after 3 hrs measured every hours for up to 7 hrs2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID1893771Inhibition of recombinant human QC using H-Gln-AMC hydrobromide as fluorogenic substrate incubated for 6 hrs by fluorometric microplate reader analysis2022ACS medicinal chemistry letters, Sep-08, Volume: 13, Issue:9
2-Amino-1,3,4-thiadiazoles as Glutaminyl Cyclases Inhibitors Increase Phagocytosis through Modification of CD47-SIRPĪ± Checkpoint.
AID614027Inhibition of Streptococcus agalactiae 4755 hyaluronidase at pH 5.0 after 30 mins by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID584550Cytotoxicity against mouse J774A1 cells2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID614059Inhibition of bovine testes hyaluronidase at 400 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614064Inhibition of bovine testes hyaluronidase at 2000 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID614058Inhibition of bovine testes hyaluronidase at 100 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1763224Thiol reactivity of the compound assessed as TNB2-depletion at 200 uM measured upto 24 hrs by TNB2-depletion assay2021European journal of medicinal chemistry, Jul-05, Volume: 219Discovery of selective fragment-sized immunoproteasome inhibitors.
AID614052Inhibition of bovine testes hyaluronidase at 49 uM after 30 mins at pH 5 by turbidimetric analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (9.72)18.7374
1990's7 (9.72)18.2507
2000's13 (18.06)29.6817
2010's34 (47.22)24.3611
2020's11 (15.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.05 (24.57)
Research Supply Index4.41 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index67.38 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.53%)5.53%
Reviews1 (1.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other76 (96.20%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]